Arkolith/Insider Trading/CAPR/Form 4

Sabar Karimah Es

DirectorCAPRICOR THERAPEUTICS, INC. (CAPR) · full profile →Form 4 · filed Apr 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.5M
Net Open-Market Flow
-$3.5M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)54K$4.86$261K54K
Apr 1, 2026Sell(S)54K$31.03$1.7M0
Mar 31, 2026Option exercise(M)61K$4.86$298K61K
Mar 31, 2026Sell(S)61K$30.17$1.8M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)54K—$00
Mar 31, 2026Option exercise(M)61K—$054K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001873796-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML